<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:e sem="disease" ids="C0238096" disease_type="Disease or Syndrome" abbrv="">Paradoxical embolism</z:e> through a <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> is a recognized cause of <z:hpo ids='HP_0001297'>stroke</z:hpo>, but clinical predictors, recurrence rate, and prevention of brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> in patients with <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> have not been determined </plain></SENT>
<SENT sid="1" pm="."><plain>We reviewed transesophageal echocardiographic records to ascertain echocardiographic predictors and optimal prophylaxis for <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo>-related <z:mpath ids='MPATH_124'>infarcts</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> was identified in 74 patients during 615 transesophageal echocardiograms by color Doppler or saline contrast during a 60-month period </plain></SENT>
<SENT sid="3" pm="."><plain>On the basis of final clinical situation, the patients were divided into the following groups: group 1, <z:mpath ids='MPATH_124'>infarct</z:mpath> with <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> a likely cause (n = 16); group 2, <z:mpath ids='MPATH_124'>infarct</z:mpath> with <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> an unlikely cause (n = 23); and group 3, no <z:mpath ids='MPATH_124'>infarct</z:mpath> (n = 35) </plain></SENT>
<SENT sid="4" pm="."><plain>Transesophageal echocardiograms were reviewed to assess <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> characteristics and associated cardio-embolic sources without knowledge of clinical details or group assignment </plain></SENT>
<SENT sid="5" pm="."><plain>Follow-up after a <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo>-related <z:mpath ids='MPATH_124'>infarct</z:mpath> was obtained by telephone or written correspondence in 15 of 16 group 1 patients </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:hpo ids='HP_0011995'>Atrial septal aneurysms</z:hpo> were more common in group 1 (38%) compared with group 2 (10%) and group 3 (8%) (P = .02) </plain></SENT>
<SENT sid="7" pm="."><plain>Contrast right-to-left shunting occurred in 88% of group 1 (P = .06) and 86% of group 2 (P = .07) compared with 60% of group 3 </plain></SENT>
<SENT sid="8" pm="."><plain>Prevention of recurrence in subjects with presumed <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo>-related brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> varied </plain></SENT>
<SENT sid="9" pm="."><plain>Aspirin was usually chosen after initial <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="8" ids="10033">Warfarin</z:chebi> and <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> closure were usually reserved for subjects with symptoms of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> while taking aspirin or those who required <z:chebi fb="8" ids="10033">warfarin</z:chebi> or cardiac surgery for other indications </plain></SENT>
<SENT sid="11" pm="."><plain>No recurrent <z:mpath ids='MPATH_124'>infarcts</z:mpath> occurred in 15 patients during a mean follow-up period of 28 months </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0011995'>Atrial septal aneurysm</z:hpo> and <z:hpo ids='HP_0001694'>right-to-left shunt</z:hpo> may be predictive of a <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> that predisposes a patient to <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>Aspirin may provide sufficient <z:mpath ids='MPATH_124'>infarct</z:mpath> prophylaxis after initial <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain><z:chebi fb="8" ids="10033">Warfarin</z:chebi> and surgical correction should likely be reserved for those in whom aspirin is not effective or those who require <z:chebi fb="8" ids="10033">warfarin</z:chebi> or cardiac surgery for other reasons until prospective studies are available </plain></SENT>
</text></document>